ArticleThe Pan African medical journal2026
Tracking multidrug-resistant bacteria: a one-year retrospective study at Moulay Ismail Military Hospital, Meknes, Morocco.
Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: antimicrobial resistance represents a major global public health concern, fueled by the growing prevalence of multidrug-resistant bacteria that limit therapeutic options. This study aims to describe the epidemiological characteristics of multidrug-resistant bacteria isolated in our facility and to evaluate their antibiotic resistance profiles. Methods: this is a retrospective and descriptive study covering one year (June 2022 to May 2023), examining the results of antibiograms performed at the bacteriology laboratory of Moulay Ismail Military Hospital in Meknes, Morocco. Results: we examined 1217 bacterial strains and found that 23.5% were multidrug-resistant. ESBL-E comprises 51% of these multidrug-resistant bacteria, followed by 6% MRSA, 19% IRAB, and 19% CPE. The intensive care unit serves as the primary source of isolation for multidrug-resistant bacteria (36%), followed by surgical services (27%). Urine is the primary reservoir for these bacteria (55%). The analysis of the resistance profile of these multidrug-resistant bacteria demonstrated a notable prevalence of resistance to various classes of antibiotics. Fortunately, most of these multidrug-resistant bacteria remain susceptible to amikacin and fosfomycin, exhibiting complete sensitivity to colistin. Conclusion: enhancing antibiotic prescribing practices and strictly implementing hygiene and preventative protocols would aid in reducing the development of multidrug-resistant organisms. An in-depth understanding of bacterial ecology and resistance profiles to various antibiotics would provide customized treatment for each medical setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.